GPAT — Stock Film
STOCK FILMSCENE 1/11GPAT · $11.05
Stock Expert AI presents
GPAT
GP-Act III Acquisition Corp
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
GP-Act III Acquisition Corp. What it actually does.

Focuses on mergers with existing businesses. Facilitates share exchanges to create combined entities. Now — the numbers.

on the stock market since 2024
2 employees
$397.1M market value
Revenue last year:
$0
The net profit left over:
$11.9M
The company reported no sales at all last year — the profit came from somewhere other than selling.

There is not enough trading history here to call this an established business.

THE SALES TREND
The sales picture, year by year.

Red columns mark years that ended in a loss.

$0
2020
2022
2023
2024
$0
2025
Cash on hand:
$113K
Total debt:
$400K
The debt outweighs the cash.

The gap is $287K. In times of high interest rates, a gap like that can squeeze a company.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
33.4×

The market pays 33.4× for every dollar this company earns in a year — a price that already assumes things go well.

Against companies in its own sector, it looks cheaper than 19% of them.

No analyst target is on record for this company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
42
weak

Clearly below the class average.

FINANCIAL STRENGTH
20
very weak

Clearly below the class average.

VALUATION
19
very weak

Clearly below the class average.

GROWTH
21
very weak

Clearly below the class average.

PRICE MOMENTUM
51
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

THE BRIGHT SIDE

Our checks did not surface a specific strength to highlight here.

1
THE RISKS · 1/3
The price runs ahead of the earnings

Today’s price already includes part of tomorrow’s optimism. Report-card grade: 19/100.

2
THE RISKS · 2/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 20/100.

3
THE RISKS · 3/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 21/100.

FINALE · THE GRADE
C
42.9 / 100 · MoonshotScore

On our five-subject report card, GPAT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: GPAT does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Aug 28, 2026 · stockexpertai.com · Stock Film